Tanaleon, Jenelyn .
HRN: 24-15-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2024
CEFUROXIME 500MG (TAB)
12/14/2024
12/21/2024
PO
500 MG
BID
S/P PRIMARY LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes